The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Taylor, Michael
    Company Director born in November 1963
    Individual (228 offsprings)
    Officer
    2018-04-11 ~ now
    OF - Director → CIF 0
    Michael Taylor
    Born in November 1963
    Individual (228 offsprings)
    Person with significant control
    2018-04-11 ~ now
    PE - Has significant influence or controlCIF 0
parent relation
Company in focus

TRANSPHARM CLINICAL CONSULTING LTD

Standard Industrial Classification
82990 - Other Business Support Service Activities N.e.c.
Brief company account
Property, Plant & Equipment
1,503 GBP2024-04-30
Debtors
725 GBP2024-04-30
2,301 GBP2023-04-30
Cash at bank and in hand
122,413 GBP2024-04-30
129,177 GBP2023-04-30
Current Assets
123,138 GBP2024-04-30
131,478 GBP2023-04-30
Net Current Assets/Liabilities
117,129 GBP2024-04-30
120,840 GBP2023-04-30
Total Assets Less Current Liabilities
118,632 GBP2024-04-30
120,840 GBP2023-04-30
Net Assets/Liabilities
118,346 GBP2024-04-30
120,840 GBP2023-04-30
Equity
Called up share capital
1 GBP2024-04-30
1 GBP2023-04-30
Retained earnings (accumulated losses)
118,345 GBP2024-04-30
120,839 GBP2023-04-30
Equity
118,346 GBP2024-04-30
120,840 GBP2023-04-30
Average Number of Employees
02023-05-01 ~ 2024-04-30
02022-05-01 ~ 2023-04-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
2,255 GBP2024-04-30
779 GBP2023-04-30
Property, Plant & Equipment - Other Disposals
Plant and equipment
-779 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
752 GBP2024-04-30
779 GBP2023-04-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
752 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Plant and equipment
-779 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment
Plant and equipment
1,503 GBP2024-04-30
Trade Debtors/Trade Receivables
600 GBP2024-04-30
2,300 GBP2023-04-30
Other Debtors
125 GBP2024-04-30
1 GBP2023-04-30
Taxation/Social Security Payable
Amounts falling due within one year
4,759 GBP2024-04-30
9,224 GBP2023-04-30
Other Creditors
Amounts falling due within one year
1,250 GBP2024-04-30
1,414 GBP2023-04-30

  • TRANSPHARM CLINICAL CONSULTING LTD
    Info
    Registered number 11304280
    International House, Cornhill, London EC3V 3NG
    Private Limited Company incorporated on 2018-04-11 (7 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2025-04-10
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.